pd 131628 has been researched along with imipenem, anhydrous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, JM; Cooper, MA; Wise, R | 1 |
| Cohen, MA; Domagala, JM; Heifetz, CL; Huband, MD; Mailloux, GB; Roland, GE; Yoder, SL | 1 |
| Cipriani, P; Filadoro, F; Giordano, A; Magni, A; Papa, F | 1 |
3 other study(ies) available for pd 131628 and imipenem, anhydrous
| Article | Year |
|---|---|
In-vitro activity of PD 131628, a new quinolone antimicrobial agent.
Topics: Anti-Infective Agents; Bacteroides fragilis; Ceftazidime; Cefuroxime; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gentamicins; Gram-Positive Bacteria; Haemophilus influenzae; Humans; Imipenem; Microbial Sensitivity Tests; Moraxella catarrhalis; Naphthyridines; Neisseria; Protein Binding; Quinolones | 1992 |
In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Naphthyridines | 1991 |
Outer membrane alterations in Pseudomonas aeruginosa after five-day exposure to quinolones and carbapenems.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Carbapenems; Cell Membrane; Ciprofloxacin; Fluoroquinolones; Imipenem; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests; Naphthyridines; Pseudomonas aeruginosa; Thienamycins; Time Factors | 1995 |